No abstract available
Publication types
-
Case Reports
-
Clinical Trial, Phase II
MeSH terms
-
Adolescent
-
Antineoplastic Agents / administration & dosage*
-
Chemotherapy, Adjuvant
-
Child
-
Disease-Free Survival
-
Female
-
Humans
-
Male
-
Protein Kinase Inhibitors / administration & dosage*
-
Proto-Oncogene Proteins c-met / antagonists & inhibitors
-
Proto-Oncogene Proteins c-met / metabolism
-
Pyrrolidinones / administration & dosage*
-
Quinolines / administration & dosage*
-
Sarcoma, Alveolar Soft Part / diagnosis
-
Sarcoma, Alveolar Soft Part / drug therapy*
-
Sarcoma, Alveolar Soft Part / enzymology
-
Sarcoma, Alveolar Soft Part / secondary
-
Thigh
-
Time Factors
-
Tomography, X-Ray Computed
-
Treatment Outcome
Substances
-
ARQ 197
-
Antineoplastic Agents
-
Protein Kinase Inhibitors
-
Pyrrolidinones
-
Quinolines
-
MET protein, human
-
Proto-Oncogene Proteins c-met